Skip to main content
TipRanks
Go Ultimate75% OFF

Soligenix (SNGX) Drug Pipeline

786 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
HypericinCutaneous T Cell Lymphoma, Mycosis Fungoides, Ctcl/ Mycosis Fungoides, CtclPhase IIIRecruitingConfirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCLJun 17, 2024―
DusquetideBehçet DiseasePhase IICompletedDusquetide for the Treatment of Behcet's DiseaseApr 23, 2024―
Hypericin, Mechlorethamine Topical GelCutaneous T-Cell Lymphoma/Mycosis FungoidesPhase IICompletedHyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCLNov 20, 2023―
HypericinPsoriasis, Plaque Psoriasis, Psoriasis VulgarisPhase IIRecruitingTopical SGX302 for Mild-to-Moderate PsoriasisJun 28, 2022―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Soligenix Inc (SNGX) have in its pipeline
Soligenix SNGX is currently developing the following drugs: Hypericin, Dusquetide, Hypericin, Mechlorethamine Topical Gel. These drug candidates are in various stages of clinical development as the company works toward FDA approval.